Certain disturbances in asprosin secretion may occur in individuals with metabolic syndrome, type 2 diabetes, or obesity; it has been shown that asprosin levels are significantly elevated in these individuals [3]. The gene discussed is FBN1; the disease is obesity due to melanocortin 4 receptor deficiency.